Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OptimizeRx Q3 Adj. EPS $0.20 Beats $0.04 Estimate, Sales $26.067M Beat $23.833M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:02pm
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.04 by 354.55 percent. This is a 66.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $26.067 million which beat the analyst consensus estimate of $23.833 million by 9.37 percent. This is a 22.33 percent increase over sales of $21.309 million the same period last year.

Posted In: OPRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist